FDA Inspection 898004 — Rundo International Pharmaceuticals
The FDA completed an inspection of Rundo International Pharmaceuticals on Sep 26, 2014 in Shanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 26, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional details
Clinical Investigator (CI)